07/06/2006 • Laboratory diagnostics

Enhancing Heart Failure Diagnosis

NT-proBNP has repeatedly been demonstrated to be a highly suitable marker for the diagnosis, prognosis and monitoring of heart failure. Heart failure is associated with high morbidity and mortality, while its unspecific symptoms make the disease difficult to identify, in particular in its early stages. NT-proBNP detects heart failure even in early stages and has been shown to be the most predictive marker for the risk stratification of re-hospitalization and mortality in patients with acute coronary syndrome. It seems to be reliable in patients with renal impairment, a condition often associated with heart failure.Elecsys pro BNP provides fast and accurate quantification of NT-proBNP in Serum and Plasma (heparin, EDTA). Used in routine lab testing results are provided within 18 minutes, which makes the test particularly valuable in the acute setting. And this even at reduced cost a study has shown that the use of Elecsys proBNP can reduce direct medical costs by 10% through savings in alternative diagnostic methods and hospital days. The well performing Immunoassay has a high specificity and sensitivity, is fully automated and easily compatible with routine workflow.References are available upon request.
This product information
is expired!

Use our search-function for current products ...
gradient arrows

Roche Diagnostics GmbH

Sandhoferstr. 116
68305 Mannheim

Phone: +49 (0) 621/ 759- 0
Fax: +49 (0) 621/ 759- 0